Suppr超能文献

美国患有精神健康障碍的成年人中处方类阿片的使用情况。

Prescription Opioid Use among Adults with Mental Health Disorders in the United States.

作者信息

Davis Matthew A, Lin Lewei A, Liu Haiyin, Sites Brian D

机构信息

From the Institute for Healthcare Policy and Innovation (MAD), the School of Nursing (MAD, HL), the Institute for Social Research (MAD), and the Addiction Center, Department of Psychiatry (LAL), University of Michigan, Ann Arbor; and the Department of Anesthesiology, Geisel School of Medicine at Dartmouth College, Hanover, NH (BDS).

出版信息

J Am Board Fam Med. 2017 Jul-Aug;30(4):407-417. doi: 10.3122/jabfm.2017.04.170112.

Abstract

BACKGROUND

The extent to which adults with mental health disorders in the United States receive opioids has not been adequately reported.

METHODS

We performed a cross-sectional study of a nationally representative sample of the noninstitutionalized U.S. adult population from the Medical Expenditure Panel Survey. We examined the relationship between mental health (mood and anxiety) disorders and prescription opioid use (defined as receiving at least 2 prescriptions in a calendar year).

RESULTS

We estimate that among the 38.6 million Americans with mental health disorders, 18.7% (7.2 million of 38.6 million) use prescription opioids. Adults with mental health conditions receive 51.4% (60 million of 115 million prescriptions) of the total opioid prescriptions distributed in the United States each year. Compared with adults without mental health disorders, adults with mental health disorders were significantly more likely to use opioids (18.7% vs 5.0%; < .001). In adjusted analyses, having a mental health disorder was associated with prescription opioid use overall (odds ratio, 2.08; 95% confidence interval, 1.83-2.35).

CONCLUSIONS

The 16% of Americans who have mental health disorders receive over half of all opioids prescribed in the United States. Improving pain management among this population is critical to reduce national dependency on opioids.

摘要

背景

美国患有精神疾病的成年人使用阿片类药物的程度尚未得到充分报道。

方法

我们对医疗支出面板调查中具有全国代表性的非机构化美国成年人口样本进行了横断面研究。我们研究了心理健康(情绪和焦虑)障碍与处方阿片类药物使用(定义为在一个日历年中至少接受2张处方)之间的关系。

结果

我们估计,在3860万患有精神疾病的美国人中,18.7%(3860万人中的720万)使用处方阿片类药物。患有精神疾病的成年人每年获得美国分发的阿片类药物处方总数的51.4%(1.15亿张处方中的6000万张)。与没有精神疾病的成年人相比,患有精神疾病的成年人使用阿片类药物的可能性显著更高(18.7%对5.0%;<0.001)。在调整分析中,患有精神疾病与总体处方阿片类药物使用相关(优势比,2.08;95%置信区间,1.83 - 2.35)。

结论

患有精神疾病的16%的美国人获得了美国开出的所有阿片类药物的一半以上。改善这一人群的疼痛管理对于减少全国对阿片类药物的依赖至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验